| 000 | 01496 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250513032528.0 | ||
| 264 | 0 | _c19951027 | |
| 008 | 199510s 0 0 eng d | ||
| 022 | _a0140-6736 | ||
| 024 | 7 |
_a10.1016/s0140-6736(95)92709-3 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRuiz, J | |
| 245 | 0 | 0 |
_aGln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes. _h[electronic resource] |
| 260 |
_bLancet (London, England) _cSep 1995 |
||
| 300 |
_a869-72 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aArginine |
| 650 | 0 | 4 | _aAryldialkylphosphatase |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 |
_aCoronary Disease _xcomplications |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 2 _xcomplications |
| 650 | 0 | 4 |
_aEsterases _xgenetics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 | _aGlutamine |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 | _aRegression Analysis |
| 650 | 0 | 4 | _aRisk Factors |
| 700 | 1 | _aBlanché, H | |
| 700 | 1 | _aJames, R W | |
| 700 | 1 | _aGarin, M C | |
| 700 | 1 | _aVaisse, C | |
| 700 | 1 | _aCharpentier, G | |
| 700 | 1 | _aCohen, N | |
| 700 | 1 | _aMorabia, A | |
| 700 | 1 | _aPassa, P | |
| 700 | 1 | _aFroguel, P | |
| 773 | 0 |
_tLancet (London, England) _gvol. 346 _gno. 8979 _gp. 869-72 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0140-6736(95)92709-3 _zAvailable from publisher's website |
| 999 |
_c7564127 _d7564127 |
||